Publication:
Thalassemia and the hypercoagulable state

dc.contributor.authorNongnuch Sirachainanen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-10-19T05:10:49Z
dc.date.available2018-10-19T05:10:49Z
dc.date.issued2013-12-01en_US
dc.description.abstractThalassemia, an inherited hemolytic disorder, is associated with a high incidence of thrombosis. The major mechanisms underlying thromboembolism (TE) are an abnormal red blood cell surface, platelet activation and endothelial cell activation. A higher risk of TE is found in splenectomized patients due to thrombocytosis and increased abnormal RBCs in the circulation. Regular RBC transfusions can reduce the proportion of abnormal RBCs and suppress erythropoiesis. Regular transfusion may also reduce levels of circulating coagulation markers and reduce elevated pulmonary artery pressure. To prevent thromboembolic events, aspirin is now recommended for splenectomized patients with thrombocytosis. © 2013 Elsevier Ltd.en_US
dc.identifier.citationThrombosis Research. Vol.132, No.6 (2013), 637-641en_US
dc.identifier.doi10.1016/j.thromres.2013.09.029en_US
dc.identifier.issn18792472en_US
dc.identifier.issn00493848en_US
dc.identifier.other2-s2.0-84889886728en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/32049
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84889886728&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleThalassemia and the hypercoagulable stateen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84889886728&origin=inwarden_US

Files

Collections